Primary malignant lymphoma of the intestine.
Primary intestinal lymphoma is uncommon but not rare. Its pathology and potential therapy are complex. Its epidemiology has changed radically over the past century, reflecting a sharp surge in the incidence of intestinal lymphoma, particularly that associated with immunosuppression. Recent advances in diagnosis, a new approach to pathologic classification by immunotyping, and a new staging system have influenced therapy. New multimodal therapeutic protocols have improved the prognosis of this once deadly disease.
Turowski
G A
GA
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062.
Basson
M D
MD
D002985:Clinical Protocols; D003131:Combined Modality Therapy; D006801:Humans; D016130:Immunophenotyping; D007414:Intestinal Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D008223:Lymphoma / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D009367:Neoplasm Staging; D011379:Prognosis; D012307:Risk Factors; D014481:United States / Q000453:epidemiology